At a glance
ClinicalIndex Comparison RecordN/ACompleted· 125 enrolled
Drug / intervention
Dilapan-Sdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective Collection of Data About the Use of the Dilapan-S Osmotic Dilator in Pre-induction of Labor in Women With/Without Caesarean Section in Their History
In Brief
An observational study evaluating Dilapan-S for Uterine Cervical Incompetence. Completed, enrolled 125 participants across 1 site.
Detailed Summary
Non-interventional prospective data collection designed to evaluate clinical outcome on the efficacy of the use of Dilapan-S in the indication of labor pre-induction in women with/without a history of Caesarean section. The evaluation will be based on prospective data collection in at least four obstetrics centers in the Czech Republic.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsUterine Cervical Incompetence
CountriesCzechia
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartMay 2013
Primary CompletionOct 2013
First PostedMar 2014
Study CompletionOct 2014
TodayJul 2026
First PostedMar 28, 2014
Enrollment StartMay 1, 2013
Primary CompletionOct 1, 2013
Study CompletionOct 1, 2014
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 12.3 years ago
Interventions
Dilapan-Sdevice
Dilapan-S synthetic osmotic dilator for cervical ripening prior to labor induction